Artificial intelligence and medical-engineering integration in diabetes management: Advances, opportunities, and challenges

Abstract

Background:Global incidence and prevalence of diabetes have been rising steadily, leading to increased disability, mortality, and a significant economic burden. Despite advances in medical care, challenges such as shortage of diabetes specialists, unequal distribution of healthcare resources, suboptimal medication adherence, and poor self-management have contributed to inadequate glycemic control in patients.
Objective:This review examines the latest advances in artificial intelligence (AI) applications for diabetes management, evaluating its potential to improve patient outcomes and reduce the economic burden on healthcare systems.
Methods:We comprehensively reviewed recent studies and clinical trials that explore the use of AI in diabetes prevention, diagnosis, and management. Key technologies such as machine learning, predictive analytics, and digital health tools were assessed for their clinical applicability and impact on patient care.
Results:AI-driven approaches, including predictive models for glycemic control, personalized treatment plans, and digital monitoring systems, have shown promising results in enhancing diabetes management. However, challenges remain in integrating these technologies into clinical practice, particularly regarding data privacy, algorithmic transparency, and training of healthcare providers.
Conclusion:While AI presents substantial opportunities for improving diabetes care and reducing healthcare costs, its successful implementation requires overcoming several barriers, including regulatory hurdles and ensuring equitable access to technology. Future research should focus on developing interoperable AI systems that seamlessly integrate into existing healthcare infrastructures and address the diverse needs of diabetic populations.

Keywords

Artificial intelligence / Diabetes / Management / Digital health

Ethics approval

Not applicable.

Funding

This study was supported by the National Natural Science Foundation of China (Grant NO.82370788).

CRediT authorship contribution statement

Shizhan Ma: Funding acquisition. Mian Zhang: Project administration, Writing-review & editing. Wenxiu Sun: Writing-original draft. Yuhan Gao: Writing-original draft. Mengzhe Jing: Writing-original draft. Ling Gao: Project administration, Funding acquisition, Supervision. Zhongming Wu: Writing-review & editing, Supervision, Funding acquisition. All the authors have read and approved the final version of this manuscript

Declaration of Competing Interest

We declare that we have no financial and personal relationships with other people or organizations that can inappropriately influence our work and there is no professional or other personal interest of any nature or kind in any product, service and/or company that could be construed as influencing the position presented in, or the review of, the manuscript titled, “Artificial intelligence and medical-engineering integration in diabetes management: Advances, opportunities, and challenges”.

Acknowledgments

We thank all contributors for their valuable contributions to this manuscript.

Data availability

Not applicable

References

[1] American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2011; 34(Suppl 1):S62-S69. https://doi.org/10.2337/dc11-S062

[2] Xu Y, Wang L, He J, et al. Prevalence and control of diabetes in Chinese adults. JAMA. 2013; 310(9):948-959. https://doi.org/10.1001/jama.2013.168118

[3] Sun H, Saeedi P, Karuranga S, et al. IDF Diabetes Atlas: global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res Clin Pract. 2022; 183:109119. https://doi.org/10.1016/j.diabres.2021.109119

[4] Ali MK, Bullard KM, Saaddine JB, Cowie CC, Imperatore G, Gregg EW. Achievement of goals in U.S. diabetes care, 1999-2010. N Engl J Med. 2013; 368(17):1613-1624. https://doi.org/10.1056/NEJMsa1213829

[5] Joslin EP.The Prevention of Diabetes Mellitus. JAMA. 2021; 325(2):190. https://doi.org/10.1001/jama.2020.17738

[6] Hamet P, Tremblay J.Artificial intelligence in medicine. Metabolism. 2017;69S:S36-S40. https://doi.org/10.1016/j.metabol.2017.01.011

[7] Frank SR. Digital health care-the convergence of health care and the Internet. J Ambul Care Manage. 2000; 23(2):8-17. https://doi.org/10.1097/00004479-200004000-00003

[8] Combi C. Editorial from the new Editor-in-Chief: artificial intelligence in medicine and the forthcoming challenges. Artif Intell Med. 2017; 76:37-39. https://doi.org/10.1016/j.artmed.2017.01.003

[9] Baumgart DC. Personal digital assistants in health care: experienced clinicians in the palm of your hand? Lancet. 2005; 366(9492):1210-1222. https://doi.org/10.1016/S0140-6736(05)67484-3

[10] Thacharodi A, Singh P, Meenatchi R, et al. Revolutionizing healthcare and medicine: The impact of modern technologies for a healthier future-A comprehensive review. Health Care Sci. 2024; 3(5):329-349. https://doi.org/10.1002/hcs2.115

[11] Stern AD, Brönneke J, Debatin JF, et al. Advancing digital health applications: priorities for innovation in real-world evidence generation. Lancet Digit Health. 2022; 4(3):e200-e206. https://doi.org/10.1016/S2589-7500(21)00292-2

[12] Shibue K. Artificial intelligence and machine learning in clinical medicine. N Engl J Med. 2023; 388(25):2398. https://doi.org/10.1056/NEJMc2305287

[13] Haug CJ, Drazen JM.Artificial intelligence and machine learning in clinical medicine, 2023. N Engl J Med. 2023; 388(13):1201-1208. https://doi.org/10.1056/NEJMra2302038

[14] Contreras I, Vehi J. Artificial Intelligence for Diabetes Management and Decision Support: Literature Review. J Med Internet Res. 2018; 20(5):e10775. https://doi.org/10.2196/10775

[15] Park SH, Han K. Methodologic Guide for Evaluating Clinical Performance and Effect of Artificial Intelligence Technology for Medical Diagnosis and Prediction. Radiology. 2018; 286(3):800-809. https://doi.org/10.1148/radiol.2017171920

[16] Liang H, Tsui BY, Ni H, et al. Evaluation and accurate diagnoses of pediatric diseases using artificial intelligence. Nat Med. 2019; 25(3):433-438. https://doi.org/10.1038/s41591-018-0335-9

[17] Jiang F, Jiang Y, Zhi H, et al. Artificial intelligence in healthcare: past, present and future. Stroke Vasc Neurol. 2017; 2(4):230-243. https://doi.org/10.1136/svn-2017-000101

[18] Elhaddad M, Hamam S. AI-Driven Clinical Decision Support Systems: An Ongoing Pursuit of Potential. Cureus. 2024; 16(4):e57728. https://doi.org/10.7759/cureus.57728

[19] Ahmed Z, Mohamed K, Zeeshan S, Dong X. Artificial intelligence with multi-functional machine learning platform development for better healthcare and precision medicine. Database (Oxford). 2020;2020:baaa010. https://doi.org/10.1093/database/baaa010

[20] Kononenko I. Machine learning for medical diagnosis: history, state of the art and perspective. Artif Intell Med. 2001; 23(1):89-109. https://doi.org/10.1016/s0933-3657(01)00077-x

[21] Topol EJ. High-performance medicine: the convergence of human and artificial intelligence. Nat Med. 2019; 25(1):44-56. https://doi.org/10.1038/s41591-018-0300-7

[22] Mittermaier M, Raza MM, Kvedar JC. Bias in AI-based models for medical applications: challenges and mitigation strategies. NPJ Digit Med. 2023; 6(1):113. https://doi.org/10.1038/s41746-023-00858-z

[23] Graham SA, Lee EE, Jeste DV, et al. Artificial intelligence approaches to predicting and detecting cognitive decline in older adults: A conceptual review. Psychiatry Res. 2020;284:112732. https://doi.org/10.1016/j.psychres.2019.112732

[24] Chen X, Xu G, Xu X, Jiang H, Tian Z, Ma T. Multicenter Hierarchical Federated Learning With Fault-Tolerance Mechanisms for Resilient Edge Computing Networks. IEEE Trans Neural Netw Learn Syst. 2024. https://doi.org/10.1109/TNNLS.2024.3362974

[25] Pilozzi A, Huang X. Overcoming Alzheimer’s Disease Stigma by Leveraging Artificial Intelligence and Blockchain Technologies. Brain Sci. 2020; 10(3):183. https://doi.org/10.3390/brainsci10030183

[26] Belge Bilgin G, Bilgin C, Burkett BJ, et al. Theranostics and artificial intelligence: new frontiers in personalized medicine. Theranostics. 2024; 14(6):2367-2378. https://doi.org/10.7150/thno.94788

[27] Chatterjee S, Khunti K, Davies MJ. Type 2 diabetes. Lancet. 2017; 389(10085):2239-2251. https://doi.org/10.1016/S0140-6736(17)30058-2

[28] Stidsen JV, Henriksen JE, Olsen MH, et al. Pathophysiology-based phenotyping in type 2 diabetes: a clinical classification tool. Diabetes Metab Res Rev. 2018; 34(5):e3005. https://doi.org/10.1002/dmrr.3005

[29] Pearson ER. Type 2 diabetes: a multifaceted disease. Diabetologia. 2019; 62(7):1107-1112. https://doi.org/10.1007/s00125-019-4909-y

[30] Lin Y, Wessel J. The continuing evolution of precision health in type 2 diabetes: achievements and challenges. Curr Diab Rep. 2019; 19(4):16. https://doi.org/10.1007/s11892-019-1137-2

[31] Ahlqvist E, Storm P, Käräjämäki A, et al. Novel subgroups of adult-onset diabetes and their association with outcomes: a data-driven cluster analysis of six variables. Lancet Diabetes Endocrinol. 2018; 6(5):361-369. https://doi.org/10.1016/S2213-8587(18)30051-2

[32] Li L, Cheng WY, Glicksberg BS, et al. Identification of type 2 diabetes subgroups through topological analysis of patient similarity. Sci Transl Med. 2015; 7(311):311ra174. https://doi.org/10.1126/scitranslmed.aaa9364

[33] Zou X, Zhou X, Zhu Z, Ji L. Novel subgroups of patients with adult-onset diabetes in Chinese and US populations. Lancet Diabetes Endocrinol. 2019; 7(1):9-11. https://doi.org/10.1016/S2213-8587(18)30316-4

[34] Wang W, Pei X, Zhang L, et al. Application of new international classification of adult-onset diabetes in Chinese inpatients with diabetes mellitus. Diabetes Metab Res Rev. 2021; 37(7):e3427. https://doi.org/10.1002/dmrr.3427

[35] Allalou A, Nalla A, Prentice KJ, et al. A predictive metabolic signature for the transition from gestational diabetes mellitus to type 2 diabetes. Diabetes. 2016; 65(9):2529-2539. https://doi.org/10.2337/db15-1720

[36] Maniruzzaman M, Kumar N, Menhazul Abedin M, et al. Comparative approaches for classification of diabetes mellitus data: Machine learning paradigm. Comput Methods Programs Biomed. 2017; 152:23-34. https://doi.org/10.1016/j.cmpb.2017.09.004

[37] Barakat NH, Bradley AP, Barakat MN. Intelligible support vector machines for diagnosis of diabetes mellitus. IEEE Trans Inf Technol Biomed. 2010; 14(4):1114-1120. https://doi.org/10.1109/TITB.2009.2039485

[38] Tanabe H, Sato M, Miyake A, et al. Machine learning-based reproducible prediction of type 2 diabetes subtypes. Diabetologia. 2024; 67(11):2446-2458. https://doi.org/10.1007/s00125-024-06248-8

[39] McCarthy MI. Painting a new picture of personalised medicine for diabetes. Diabetologia. 2017; 60(5):793-799. https://doi.org/10.1007/s00125-017-4210-x

[40] Noble D, Mathur R, Dent T, Meads C, Greenhalgh T. Risk models and scores for type 2 diabetes: systematic review. BMJ. 2011;343:d7163. https://doi.org/10.1136/bmj.d7163

[41] Farran B, Channanath AM, Behbehani K, Thanaraj TA. Predictive models to assess risk of type 2 diabetes, hypertension and comorbidity: machine-learning algorithms and validation using national health data from Kuwait-a cohort study. BMJ Open. 2013; 3(5):e002457. https://doi.org/10.1136/bmjopen-2012-002457

[42] Choi SB, Kim WJ, Yoo TK, et al. Screening for prediabetes using machine learning models. Comput Math Methods Med. 2014;2014:618976. https://doi.org/10.1155/2014/618976

[43] Casanova R, Saldana S, Simpson SL, et al. Prediction of Incident Diabetes in the Jackson Heart Study Using High-Dimensional Machine Learning. PLoS One. 2016; 11(10):e0163942. https://doi.org/10.1371/journal.pone.0163942

[44] Dinh A, Miertschin S, Young A, Mohanty SD. A data-driven approach to predicting diabetes and cardiovascular disease with machine learning. BMC Med Inform Decis Mak. 2019; 19(1):211. https://doi.org/10.1186/s12911-019-0918-5

[45] Xiong XL, Zhang RX, Bi Y, Zhou WH, Yu Y, Zhu DL. Machine Learning Models in Type 2 Diabetes Risk Prediction: Results from a Cross-sectional Retrospective Study in Chinese Adults. Curr Med Sci. 2019; 39(4):582-588. https://doi.org/10.1007/s11596-019-2077-4

[46] Amann J, Blasimme A, Vayena E, Frey D, Madai VI. Explainability for artificial intelligence in healthcare: a multidisciplinary perspective. BMC Med Inform Decis Mak. 2020; 20(1):310. https://doi.org/10.1186/s12911-020-01332-6

[47] Loftus TJ, Shickel B, Ozrazgat-Baslanti T, et al. Artificial intelligence-enabled decision support in nephrology. Nat Rev Nephrol. 2022; 18(7):452-465. https://doi.org/10.1038/s41581-022-00562-3

[48] Hafidh K, Malek R, Al-Rubeaan K, et al. Prevalence and risk factors of vascular complications in type 2 diabetes mellitus: Results from discover Middle East and Africa cohort. Front Endocrinol (Lausanne). 2022;13:940309. https://doi.org/10.3389/fendo.2022.940309

[49] Litwak L, Goh SY, Hussein Z, Malek R, Prusty V, Khamseh ME. Prevalence of diabetes complications in people with type 2 diabetes mellitus and its association with baseline characteristics in the multinational A1chieve study. Diabetol Metab Syndr. 2013; 5(1):57. https://doi.org/10.1186/1758-5996-5-57

[50] Bilous R. Blood pressure control in type 2 diabetes-what does the United Kingdom Prospective Diabetes Study (UKPDS) tell us? Nephrol Dial Transplant. 1999; 14(11):2562-2564. https://doi.org/10.1093/ndt/14.11.2562

[51] Stevens RJ, Kothari V, Adler AI, Stratton IM, Holman RR. The UKPDS risk engine: a model for the risk of coronary heart disease in Type II diabetes (UKPDS 56). Clin Sci (Lond). 2001; 101(6):671-679. https://doi.org/10.1042/cs1010671

[52] Clarke PM, Gray AM, Briggs A, et al. A model to estimate the lifetime health outcomes of patients with type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS) Outcomes Model (UKPDS no. 68). Diabetologia. 2004; 47(10):1747-1759. https://doi.org/10.1007/s00125-004-1527-z

[53] Gulshan V, Peng L, Coram M, et al. Development and Validation of a Deep Learning Algorithm for Detection of Diabetic Retinopathy in Retinal Fundus Photographs. JAMA. 2016; 316(22):2402-2410. https://doi.org/10.1001/jama.2016.17216

[54] Zhang Y, Shi J, Peng Y, et al. Artificial intelligence-enabled screening for diabetic retinopathy: a real-world, multicenter and prospective study. BMJ Open Diabetes Res Care. 2020; 8(1):e001596. https://doi.org/10.1136/bmjdrc-2020-001596

[55] Ting DSW, Cheung CY, Lim G, et al. Development and Validation of a Deep Learning System for Diabetic Retinopathy and Related Eye Diseases Using Retinal Images From Multiethnic Populations With Diabetes. JAMA. 2017; 318(22):2211-2223. https://doi.org/10.1001/jama.2017.18152

[56] Abràmoff MD, Lavin PT, Birch M, Shah N, Folk JC. Pivotal trial of an autonomous AI-based diagnostic system for detection of diabetic retinopathy in primary care offices. NPJ Digit Med. 2018;1:39. https://doi.org/10.1038/s41746-018-0040-6

[57] Verbraak FD, Abramoff MD, Bausch GCF, et al. Diagnostic Accuracy of a Device for the Automated Detection of Diabetic Retinopathy in a Primary Care Setting. Diabetes Care. 2019; 42(4):651-656. https://doi.org/10.2337/dc18-0148

[58] Lin S, Ma Y, Xu Y, et al. Artificial Intelligence in Community-Based Diabetic Retinopathy Telemedicine Screening in Urban China: Cost-effectiveness and Cost-Utility Analyses With Real-world Data. JMIR Public Health Surveill. 2023;9:e41624. https://doi.org/10.2196/41624

[59] Liu F, Bao Y, Hu R, et al. Screening and prevalence of peripheral neuropathy in type 2 diabetic outpatients: a randomized multicentre survey in 12 city hospitals of China. Diabetes Metab Res Rev. 2010; 26(6):481-489. https://doi.org/10.1002/dmrr.1107

[60] Rahman M, Griffin SJ, Rathmann W, Wareham NJ. How should peripheral neuropathy be assessed in people with diabetes in primary care? A population-based comparison of four measures. Diabet Med. 2003; 20(5):368-374. https://doi.org/10.1046/j.1464-5491.2003.00931.x

[61] Rahmani Katigari M, Ayatollahi H, Malek M, Kamkar Haghighi M. Fuzzy expert system for diagnosing diabetic neuropathy. World J Diabetes. 2017; 8(2):80-88. https://doi.org/10.4239/wjd.v8.i2.80

[62] Fan R, Zhang N, Yang L, Ke J, Zhao D, Cui Q. AI-based prediction for the risk of coronary heart disease among patients with type 2 diabetes mellitus. Sci Rep. 2020; 10(1):14457. https://doi.org/10.1038/s41598-020-71321-2

[63] Makino M, Yoshimoto R, Ono M, et al. Artificial intelligence predicts the progression of diabetic kidney disease using big data machine learning. Sci Rep. 2019; 9(1):11862. https://doi.org/10.1038/s41598-019-48263-5

[64] Katsuki T, Ono M, Koseki A, et al. Risk Prediction of Diabetic Nephropathy via Interpretable Feature Extraction from EHR Using Convolutional Autoencoder. Stud Health Technol Inform. 2018;247:106-110.

[65] Wang C, Zhang T, Wang P, et al. Bone metabolic biomarker-based diagnosis of type 2 diabetes osteoporosis by support vector machine. Ann Transl Med. 2021; 9(4):316. https://doi.org/10.21037/atm-20-3388

[66] Jain RK, Lee E, Mathai C, et al. Using opportunistic screening with abdominal CT to identify osteoporosis and osteopenia in patients with diabetes. Osteoporos Int. 2020; 31(11):2189-2196. https://doi.org/10.1007/s00198-020-05521-x

[67] Alotaibi MM, Istepanian R, Philip N. A mobile diabetes management and educational system for type-2 diabetics in Saudi Arabia (SAED). Mhealth. 2016;2:33. https://doi.org/10.21037/mhealth.2016.08.01

[68] Hamon T, Gagnayre R. Improving knowledge of patient skills thanks to automatic analysis of online discussions. Patient Educ Couns. 2013; 92(2):197-204. https://doi.org/10.1016/j.pec.2013.05.012

[69] Chen S, Lu J, Peng D, et al. Effect of a Mobile Health Technology-Based Diabetes Education Program on Glucose Control in Patients With Type 2 Diabetes Initiating Premixed Insulin: A Prospective, Multicenter, Observational Study. Diabetes Care. 2023; 46(1):e6-e7. https://doi.org/10.2337/dc22-0510

[70] Edlitz Y, Segal E. Prediction of type 2 diabetes mellitus onset using logistic regression-based score cards. Elife. 2022;11:e71862. https://doi.org/10.7554/eLife.71862

[71] Zeevi D, Korem T, Zmora N, et al. Personalized Nutrition by Prediction of Glycemic Responses. Cell. 2015; 163(5):1079-1094. https://doi.org/10.1016/j.cell.2015.11.001

[72] Basu S, Raghavan S, Wexler DJ, Berkowitz SA. Characteristics Associated With Decreased or Increased Mortality Risk From Glycemic Therapy Among Patients With Type 2 Diabetes and High Cardiovascular Risk: Machine Learning Analysis of the ACCORD Trial. Diabetes Care. 2018; 41(3):604-612. https://doi.org/10.2337/dc17-2252

[73] Tyler NS, Mosquera-Lopez CM, Wilson LM, et al. An artificial intelligence decision support system for the management of type 1 diabetes. Nat Metab. 2020; 2(7):612-619. https://doi.org/10.1038/s42255-020-0212-y

[74] Pesl P, Herrero P, Reddy M, et al. Case-Based Reasoning for Insulin Bolus Advice. J Diabetes Sci Technol. 2017; 11(1):37-42. https://doi.org/10.1177/1932296816629986

[75] Bergenstal RM, Johnson M, Passi R, et al. Automated insulin dosing guidance to optimise insulin management in patients with type 2 diabetes: a multicentre, randomised controlled trial. Lancet. 2019; 393(10176):1138-1148. https://doi.org/10.1016/S0140-6736(19)30368-X

[76] Fong S, Zhang Y, Fiaidhi J, Mohammed O, Mohammed S. Evaluation of stream mining classifiers for real-time clinical decision support system: a case study of blood glucose prediction in diabetes therapy. Biomed Res Int. 2013;2013:274193. https://doi.org/10.1155/2013/274193

[77] Wang Y, Fu H, Zeng D. Learning Optimal Personalized Treatment Rules in Consideration of Benefit and Risk: with an Application to Treating Type 2 Diabetes Patients with Insulin Therapies. J Am Stat Assoc. 2018; 113(521):1-13. https://doi.org/10.1080/01621459.2017.1303386

[78] Nguyen M, Jankovic I, Kalesinskas L, Baiocchi M, Chen JH. Machine learning for initial insulin estimation in hospitalized patients. J Am Med Inform Assoc. 2021; 28(10):2212-2219. https://doi.org/10.1093/jamia/ocab099

[79] Forlenza GP. Use of Artificial Intelligence to Improve Diabetes Outcomes in Patients Using Multiple Daily Injections Therapy. Diabetes Technol Ther. 2019; 21(S2):S24-S28. https://doi.org/10.1089/dia.2019.0077

[80] Zhou K, Isaacs D. Closed-Loop Artificial Pancreas Therapy for Type 1 Diabetes. Curr Cardiol Rep. 2022; 24(9):1159-1167. https://doi.org/10.1007/s11886-022-01733-1

[81] Reddy M, Pesl P, Xenou M, et al. Clinical Safety and Feasibility of the Advanced Bolus Calculator for Type 1 Diabetes Based on Case-Based Reasoning: A 6-Week Nonrandomized Single-Arm Pilot Study. Diabetes Technol Ther. 2016; 18(8):487-493. https://doi.org/10.1089/dia.2015.0413

[82] Daskalaki E, Diem P, Mougiakakou SG. Model-Free Machine Learning in Biomedicine: Feasibility Study in Type 1 Diabetes. PLoS One. 2016; 11(7):e0158722. https://doi.org/10.1371/journal.pone.0158722

[83] DeJournett L, DeJournett J. In Silico Testing of an Artificial-Intelligence-Based Artificial Pancreas Designed for Use in the Intensive Care Unit Setting. J Diabetes Sci Technol. 2016; 10(6):1360-1371. https://doi.org/10.1177/1932296816653967

[84] San PP, Ling SH, Nguyen HT. Deep learning framework for detection of hypoglycemic episodes in children with type 1 diabetes. 2016 38th Annu Int Conf IEEE Eng Med Biol Soc (EMBC). 2016:3503-3506. https://doi.org/10.1109/EMBC.2016.7591483

[85] Papazafiropoulou AK. Diabetes management in the era of artificial intelligence. Arch Med Sci Atheroscler Dis. 2024;9:e122-e128. https://doi.org/10.5114/amsad/183420

[86] Nimri R, Oron T, Muller I, et al. Adjustment of Insulin Pump Settings in Type 1 Diabetes Management: Advisor Pro Device Compared to Physicians’ Recommendations. J Diabetes Sci Technol. 2022; 16(2):364-372. https://doi.org/10.1177/1932296820965561

[87] Abraham SB, Arunachalam S, Zhong A, Agrawal P, Cohen O, McMahon CM. Improved Real-World Glycemic Control With Continuous Glucose Monitoring System Predictive Alerts. J Diabetes Sci Technol. 2021; 15(1):91-97. https://doi.org/10.1177/1932296819859334

[88] Everett E, Kane B, Yoo A, Dobs A, Mathioudakis N. A Novel Approach for Fully Automated, Personalized Health Coaching for Adults with Prediabetes: Pilot Clinical Trial. J Med Internet Res. 2018; 20(2):e72. https://doi.org/10.2196/jmir.9723

[89] Sun T, Xu Y, Xie H, Ma Z, Wang Y. Intelligent Personalized Exercise Prescription Based on an eHealth Promotion System to Improve Health Outcomes of Middle-Aged and Older Adult Community Dwellers: Pretest-Posttest Study. J Med Internet Res. 2021; 23(5):e28221. https://doi.org/10.2196/28221

[90] Kitagishi Y, Nakanishi A, Minami A, et al. Certain Diet and Lifestyle May Contribute to Islet β-cells Protection in Type-2 Diabetes via the Modulation of Cellular PI3K/ AKT Pathway. Open Biochem J. 2014; 8:74-82. https://doi.org/10.2174/1874091X01408010074

[91] Lee CS, Wang MH, Hagras H. A Type-2 Fuzzy Ontology and Its Application to Personal Diabetic-Diet Recommendation. IEEE Transactions on Fuzzy Systems. 2010; 18(2):374-395. https://doi.org/10.1109/TFUZZ.2010.2042454

[92] Khan AS, Hoffmann A. Building a case-based diet recommendation system without a knowledge engineer. Artif Intell Med. 2003; 27(2):155-179. https://doi.org/10.1016/s0933-3657(02)00113-6

[93] Norouzi S, Nematy M, Zabolinezhad H, Sistani S, Etminani K. Food recommender systems for diabetic patients: a narrative review. Reviews in Clinical Medicine. 2017; 4:128-130. https://doi.org/10.22038/RCM.2017.10814.1134

[94] Marji, Ratnawati DE. Mobile-based expert system for human diet planning using optimum neighbor. 2016 International Conference on Advanced Computer Science and Information Systems (ICACSIS). 2016:283-287. https://doi.org/10.1109/ICACSIS.2016.7872802

[95] Schoeller DA. Limitations in the assessment of dietary energy intake by self-report. Metabolism. 1995; 44(2Suppl 2): 18-22. https://doi.org/10.1016/0026-0495(95)90204-x

[96] Zhu F, Bosch M, Boushey CJ, Delp EJ. An image analysis system for dietary assessment and evaluation. Proc Int Conf Image Proc. 2010:1853-1856. https://doi.org/10.1109/ICIP.2010.5650848

[97] Rhyner D, Loher H, Dehais J, et al. Carbohydrate Estimation by a Mobile Phone-Based System Versus Self-Estimations of Individuals With Type 1 Diabetes Mellitus: A Comparative Study. J Med Internet Res. 2016; 18(5):e101. https://doi.org/10.2196/jmir.5567

[98] Chen HC, Jia W, Li Z, Sun YN, Sun M. 3D/2D Model-to-image registration for quantitative dietary assessment. Proc IEEE Annu Northeast Bioeng Conf. 2012; 2012:95-96. https://doi.org/10.1109/NEBC.2012.6206979

[99] Pouladzadeh P, Shirmohammadi S, Yassine A. Using graph cut segmentation for food calorie measurement. 2014 IEEE International Symposium on Medical Measurements and Applications (MeMeA). 2014:1-6. https://doi.org/10.1109/MeMeA.2014.6860137

[100] He H, Kong F, Tan J. DietCam: Multiview Food Recognition Using a Multikernel SVM. IEEE J Biomed Health Inform. 2016; 20(3):848-855. https://doi.org/10.1109/JBHI.2015.2419251

[101] Kogias K, Andreadis I, Dalakleidi K, Nikita KS. A Two-Level Food Classification System For People With Diabetes Mellitus Using Convolutional Neural Networks. Annu Int Conf IEEE Eng Med Biol Soc. 2018; 2018:2603-2606. https://doi.org/10.1109/EMBC.2018.8512839

[102] McAllister P, Zheng H, Bond R, Moorhead A. Combining deep residual neural network features with supervised machine learning algorithms to classify diverse food image datasets. Comput Biol Med. 2018; 95:217-233. https://doi.org/10.1016/j.compbiomed.2018.02.008

[103] Vasiloglou MF, Mougiakakou S, Aubry E, et al. A Comparative Study on Carbohydrate Estimation: GoCARB vs. Dietitians. Nutrients. 2018; 10(6):741. https://doi.org/10.3390/nu10060741

[104] Zhang W, Yu Q, Siddiquie B, Divakaran A, Sawhney H. “Snap-n-Eat”: Food Recognition and Nutrition Estimation on a Smartphone. J Diabetes Sci Technol. 2015; 9(3):525-533. https://doi.org/10.1177/1932296815582222

[105] Li S, Yu C, Li Y, et al. Study design and baseline characteristics of inpatients with diabetes mellitus in a tertiary hospital in China: A database study based on electronic medical records. J Evid Based Med. 2018; 11(3):152-157. https://doi.org/10.1111/jebm.12291

[106] Ramos M, Khalpey Z, Lipsitz S, et al. Relationship of perioperative hyperglycemia and postoperative infections in patients who undergo general and vascular surgery. Ann Surg. 2008; 248(4):585-591. https://doi.org/10.1097/SLA.0b013e31818990d1

[107] Li P, Wu T, Chen M, Zhou B, Xu WG. A study on building data warehouse of hospital information system. Chin Med J (Engl). 2011; 124(15):2372-2377. https://doi.org/10.3760/cma.j.issn.0366-6999.2011.15.022

[108] Sheen YJ, Huang CC, Huang SC, Lin CH, Lee IT, Sheu WH-H. Electronic dashboard-based remote glycemic management program reduces length of stay and readmission rate among hospitalized adults. J Diabetes Investig. 2021; 12(9):1697-1707. https://doi.org/10.1111/jdi.13500

[109] Mackey PA, Boyle ME, Walo PM, Castro JC, Cheng MR, Cook CB. Care directed by a specialty-trained nurse practioner or physician assistant can overcome clinical inertia in management of inpatient diabetes. Endocr Pract. 2014; 20(2):112-119. https://doi.org/10.4158/EP13201.OR

[110] Mularski KS, Yeh CP, Bain JK, Mosen DM, Hill AK, Mularski RA. Pharmacist glycemic control team improves quality of glycemic control in surgical patients with perioperative dysglycemia. Perm J. 2012; 16(1):28-33. https://doi.org/10.7812/TPP/11-131

[111] Warrington L, Ayers P, Baldwin AM, et al. Implementation of a pharmacist-led, multidisciplinary diabetes management team. Am J Health Syst Pharm. 2012; 69(14):1240-1245. https://doi.org/10.2146/ajhp110297

[112] Rushakoff RJ, Sullivan MM, MacMaster HW, et al. Association Between a Virtual Glucose Management Service and Glycemic Control in Hospitalized Adult Patients: An Observational Study. Ann Intern Med. 2017; 166(9):621-627. https://doi.org/10.7326/M16-1413

[113] Kyi M, Colman PG, Wraight PR, et al. Early Intervention for Diabetes in Medical and Surgical Inpatients Decreases Hyperglycemia and Hospital-Acquired Infections: A Cluster Randomized Trial. Diabetes Care. 2019; 42(5):832-840. https://doi.org/10.2337/dc18-2342

[114] Davidson PC, Steed RD, Bode BW. Glucommander: a computer-directed intravenous insulin system shown to be safe, simple, and effective in 120,618 h of operation. Diabetes Care. 2005; 28(10):2418-2423. https://doi.org/10.2337/diacare.28.10.2418

[115] Dubois J, Van Herpe T, van Hooijdonk RT, et al. Software-guided versus nurse-directed blood glucose control in critically ill patients: the LOGIC-2 multicenter randomized controlled clinical trial. Crit Care. 2017; 21(1):212. https://doi.org/10.1186/s13054-017-1799-6

[116] Meyfroidt G, Wouters P, De Becker W, Cottem D, Van den Berghe G. Impact of a computer-generated alert system on the quality of tight glycemic control. Intensive Care Med. 2011; 37(7):1151-1157. https://doi.org/10.1007/s00134-011-2159-7

[117] Colpaert K, Oeyen S, Sijnave B, Peleman R, Benoit D. Decruyenaere J. Influence of smart real-time electronic alerting on glucose control in critically ill patients. J Crit Care. 2015; 30(1):216.e1-216.e6. https://doi.org/10.1016/j.jcrc.2014.07.030

[118] Ehrenfeld JM, Wanderer JP, Terekhov M, Rothman BS, Sandberg WS. A Perioperative Systems Design to Improve Intraoperative Glucose Monitoring Is Associated with a Reduction in Surgical Site Infections in a Diabetic Patient Population. Anesthesiology. 2017; 126(3):431-440. https://doi.org/10.1097/ALN.0000000000001516

[119] Kyi M, Wraight PR, Rowan LM, Marley KA, Colman PG, Fourlanos S. Glucose alert system improves health professional responses to adverse glycaemia and reduces the number of hyperglycaemic episodes in non-critical care inpatients. Diabet Med. 2018; 35(6):816-823. https://doi.org/10.1111/dme.13623

[120] Khanna NN, Maindarkar MA, Viswanathan V, et al. Economics of Artificial Intelligence in Healthcare: Diagnosis vs Treatment. Healthcare. 2022; 10(12):2493. https://doi.org/10.3390/healthcare10122493

[121] Iqbal J, Cortés Jaimes DC, Makineni P, et al. Reimagining Healthcare: Unleashing the Power of Artificial Intelligence in Medicine. Cureus. 2023; 15(9):e44658. https://doi.org/10.7759/cureus.44658

[122] Kaliappan J, Saravana Kumar IJ, Sundaravelan S, et al. Analyzing classification and feature selection strategies for diabetes prediction across diverse diabetes datasets. Front Artif Intell. 2024;7:1421751. https://doi.org/10.3389/frai.2024.1421751

[123] Tasin I, Nabil TU, Islam S, Khan R. Diabetes prediction using machine learning and explainable AI techniques. Healthc Technol Lett. 2022; 10(1-2):1-10. https://doi.org/10.1049/htl2.12039

[124] Edeh MO, Khalaf OI, Tavera CA, et al. A Classification Algorithm-Based Hybrid Diabetes Prediction Model. Front Public Health. 2022;10:829519. https://doi.org/10.3389/fpubh.2022.829519